ANTIGEN-BINDING CONSTRUCTS THAT BIND TO AND INHIBIT CATALASE AND/OR SUPEROXIDE DISMUTASE AS WELL AS PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FOR TUMOR THERAPY
The invention relates to single domain VHH fragments which specifically bind to and inhibit superoxide dismutase and/or bind to and inhibit catalase and/or bind to and inhibit superoxide dismutase and catalase, in particular for the use in the therapy of tumor diseases.